Skip to main content
. 2021 Oct 8;27(5):1911–1923. doi: 10.1007/s10741-021-10177-8

Fig. 5.

Fig. 5

Flow of Barth syndrome patients in the TAZPOWER (SPIBA-201) Trial [16]. Used with permission from [16]